Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CryoPort (CYRX) Stock Price & Analysis
541 Followers
CYRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.00 - $23.50
Previous Close$13.46
Volume934.77K
Average Volume (3M)476.03K
Market Cap
$646.50M
Enterprise Value$622.25M
Total Cash (Recent Filing)$456.75M
Total Debt (Recent Filing)$416.00M
Price to Earnings (P/E)-5.4
Beta2.43
Next Earnings
Aug 08, 2024EPS Estimate
-$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.47
Shares Outstanding48,977,476
10 Day Avg. Volume479,881
30 Day Avg. Volume476,032
Standard Deviation0.20
R-Squared0.18
Alpha0.00445
Financial Highlights & Ratios
Price to Book (P/B)5.02
Price to Sales (P/S)2.77
Price to Cash Flow (P/CF)80.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.67
Enterprise Value/Gross Profit3.43
Enterprise Value/Ebitda-10.01
Forecast
1Y Price Target
$18.14Price Target Upside34.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
CryoPort News
Bulls Say, Bears Say
Bulls Say
Company PerformanceCYRX's risk/reward remains favorable leading analysts to reiterate a Buy rating due to the company's focus on returning to positive EBITDA and cost reduction efforts.
Market OutlookCell & gene therapy clinical trials have reached a record level, indicating a robust investment in research and development, which bodes well for the future growth of the sector.
Strategic DevelopmentsThe strategic divestiture of the freezer business positions BLFS as a more focused player in the high-growth cell and gene therapy space, with potential for higher revenue and margins.
Bears Say
Financial Performance1Q24 revenue missed consensus; Revenue of $54.6M missed BTIG / consensus estimates, and adjusted EBITDA was also below estimates.
Market DemandLife sciences products revenue declined while CYRX continues to face a challenging demand environment and pressure on MVE.
Profitability OutlookLimited visibility on generating profit as commercial CGTs stall, with flat sales from the CGTs tracked over four consecutive quarters.
---
Ownership Overview
3.28% Insiders
34.30% Mutual Funds
26.87% Other Institutional Investors
35.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $9.00 and its highest was $23.50 in the past 12 months.
What is CryoPort Inc’s market cap?
Currently, no data Available
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Aug 08, 2024 which is in 90 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on May 07, 2024. The company reported -$0.43 earnings per share for the quarter, missing the consensus estimate of -$0.345 by -$0.085.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -$0.39.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 49,257,442 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.43 in its last earnings report, missing expectations of -$0.345. Following the earnings report the stock price went down -19.512%.
Which hedge fund is a major shareholder of CryoPort Inc?
Among the largest hedge funds holding CryoPort Inc’s share is Blackstone Inc.. It holds CryoPort Inc’s shares valued at 7M.
---
CryoPort Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.14 (34.77% Upside)
$18.14 (34.77% Upside)
Blogger Sentiment
Bullish
CYRX Sentiment 66%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $132.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-40.54%
12-Months-Change
Fundamentals
Return on Equity
-21.87%
Trailing 12-Months
Asset Growth
-10.04%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
---
CYRX Earnings Call
Q1 2024
0:00 / 0:00
---
CYRX Stock 12 Month Forecast
Average Price Target
$18.14
▲(34.77% Upside)
Technical Analysis
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
2/21 ratings generated profit
1 Year Average Return
-29.90%
reiterated a buy rating 3 days ago
Copying David Saxon's trades and holding each position for 1 Year would result in 9.52% of your transactions generating a profit, with an average return of -29.90% per trade.
---